FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/01/101381 [Registered on: 16/01/2026] Trial Registered Prospectively
Last Modified On: 02/01/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Comparative Study of Two Homoeopathic Treatment Methods (Mother Tincture and Centesimal Potency) for Hemorrhoids in Adults, Assessing Symptom Improvement 
Scientific Title of Study   A Comparative Clinical Study Of Centesimal Potency Vs. Mother Tincture In The Homoeopathic Management Of Hemorrhoids Using Hemorrhoid Severity Score In Adults 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Chandni Pravinbhai Fataniya 
Designation  PG scholar 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University 
Address  OPD Room number 102 Jawaharlal Nehru Homoeopathic Medical College and Hospital Waghodia Vadodara Gujarat India 391760

Vadodara
GUJARAT
391760
India 
Phone  9033415831  
Fax    
Email  chnadnifataniya22@gmail.com  
 
Details of Contact Person
Scientific Query  
Name  Dr Partha Sarathi Mandal 
Designation  BHMS, MD Homoeopathy, HoD PG Department of Organon of Medicine and Homoeopathic Philosophy 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University 
Address  PG Department of Organon of Medicine and Homoeopathic Philosophy Jawaharlal Nehru Homoeopathic Medical College and Hospital Waghodia Vadodara Gujarat India 391760

Vadodara
GUJARAT
391760
India 
Phone  9375095471  
Fax    
Email  partha.mandal27317@paruluniversity.ac.in  
 
Details of Contact Person
Public Query  
Name  Dr Chandni Pravinbhai Fataniya 
Designation  PG scholar 
Affiliation  Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University 
Address  OPD Room number 102 Jawaharlal Nehru Homoeopathic Medical College and Hospital Waghodia Vadodara Gujarat India 391760

Vadodara
GUJARAT
391760
India 
Phone  9033415831  
Fax    
Email  chnadnifataniya22@gmail.com  
 
Source of Monetary or Material Support  
Jawaharlal Nehru Homeopathic Medical College and Hospital, Parul University, Vadodara, Gujarat  
 
Primary Sponsor  
Name  Jawaharlal Nehru Homoeopathic Medical College and Hospital, Parul University 
Address  Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University Waghodia Vadodara Gujarat India 391760 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Chandni Pravinbhai Fataniya  Jawaharlal Nehru Homoeopathic Medical College and Hospital  OPD Room number 102, Department of surgery, Jawaharlal Nehru Homoeopathic Medical College and Hospital Parul University Waghodia Vadodara Gujarat India 391760
Vadodara
GUJARAT 		 09033415831

chandnifataniya22@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Jawaharlal Nehru Homeopathic Medical College and Hospital. Institutional Ethics Committee for Human Research   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K649||Unspecified hemorrhoids,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homeopathic Medicine   Homoeopathic Medicines with Centesimal potency. Each dose will be directed to be taken orally on clean tongue with empty stomach. Duration of therapy 3 months with follow up at every 15 days 
Comparator Agent  Homoeopathic Mother Tinctures  On basis of symptom similarity Homoeopathic mother tincture will be selected, given 10 drops of as per requirement of patient with repetition every 15 days for 3 months, doses can be tapered down during the study based on symptom similarity found in patients. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Age group between 18 to 60 years.
2. Patients diagnosed with Grade I to Grade III hemorrhoids, based on clinical examination.
3. Patients willing to undergo homoeopathic treatment.
4. Patients who give written informed consent to participate in the study. 
 
ExclusionCriteria 
Details  1. Patients with Grade IV hemorrhoids, thrombosed hemorrhoids, severe bleeding or requiring emergency care.
2. Pregnant or lactating women.
3. Patients under ongoing allopathic or Ayurvedic treatment for hemorrhoids who are not willing to continue it during the study 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Marked Improvement
Moderate Improvement
Mild Improvement
Status quo
Any increase in Hemorrhoid severity score from the baseline score will be counted as worse 		 6 Months 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   27/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Hemorrhoids are a common anorectal disorder presenting with symptoms such as bleeding pain prolapse itching and discomfort. Homeopathic medicines are used in different dosage forms including centesimal potencies and mother tinctures. However there is limited clinical evidence comparing their role when medicines are prescribed based on the totality of symptoms.
This study is a prospective interventional clinical study conducted to compare the role of centesimal potency and mother tincture in the treatment of hemorrhoids in adults. A total of sixty patients diagnosed with Grade I to Grade III hemorrhoids will be included and divided into two groups. In both groups medicines will be prescribed on the basis of the totality of symptoms. One group will receive the selected medicine in centesimal potency while the other group will receive the selected medicine in mother tincture form.
The primary purpose of the study is to assess and compare the change in Hemorrhoid Severity Score before and after treatment in both groups. The study hypothesizes that there is a significant difference between centesimal potency and mother tincture in reducing the severity of hemorrhoidal symptoms in adults when prescribed according to symptom totality.
This prospective, interventional, single arm clinical study aims to compare the role of centesimal potency and mother tincture in the homeopathic management of hemorrhoids. Sixty eligible participants will be recruited from Jawaharlal Nehru Homoeopathic Medical College and Hospital, Vadodara, Gujarat, over a study period of one year. The pain, limitations and treatment outcomes will be assessed using the Hemorrhoid severity score.
 
Close